- Home
- ERAS vs TRAK Comparison
ERAS vs TRAK Comparison
Compare ERAS & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- TRAK
- Stock Information
- Founded
- ERAS 2018
- TRAK 1990
- Country
- ERAS United States
- TRAK United States
- Employees
- ERAS N/A
- TRAK N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- TRAK EDP Services
- Sector
- ERAS Health Care
- TRAK Technology
- Exchange
- ERAS Nasdaq
- TRAK Nasdaq
- Market Cap
- ERAS 396.6M
- TRAK 390.1M
- IPO Year
- ERAS 2021
- TRAK 1998
- Fundamental
- Price
- ERAS $1.43
- TRAK $22.06
- Analyst Decision
- ERAS Strong Buy
- TRAK Strong Buy
- Analyst Count
- ERAS 6
- TRAK 1
- Target Price
- ERAS $4.83
- TRAK $24.00
- AVG Volume (30 Days)
- ERAS 1.5M
- TRAK 44.3K
- Earning Date
- ERAS 05-20-2025
- TRAK 05-15-2025
- Dividend Yield
- ERAS N/A
- TRAK 0.34%
- EPS Growth
- ERAS N/A
- TRAK 14.28
- EPS
- ERAS N/A
- TRAK 0.32
- Revenue
- ERAS N/A
- TRAK $21,199,507.00
- Revenue This Year
- ERAS N/A
- TRAK $15.61
- Revenue Next Year
- ERAS N/A
- TRAK $15.00
- P/E Ratio
- ERAS N/A
- TRAK $67.32
- Revenue Growth
- ERAS N/A
- TRAK 6.99
- 52 Week Low
- ERAS $1.01
- TRAK $14.23
- 52 Week High
- ERAS $3.45
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- ERAS 52.92
- TRAK 61.82
- Support Level
- ERAS $1.37
- TRAK $21.29
- Resistance Level
- ERAS $1.61
- TRAK $22.25
- Average True Range (ATR)
- ERAS 0.14
- TRAK 0.53
- MACD
- ERAS 0.00
- TRAK 0.06
- Stochastic Oscillator
- ERAS 53.09
- TRAK 72.15
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.